Navigation Links
New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)
Date:5/14/2008

2 percent), dizziness (9 percent vs 2 percent), and upper respiratory tract infection (7 percent vs 0 percent).

No initial dosage adjustments are recommended with BENICAR in elderly, in moderate to marked renal impairment (creatinine clearance < 40 mL/min), or in hepatic dysfunction. In patients with possible depletion of intravascular volume (e.g., patients on diuretics, particularly with impaired renal function), BENICAR should be initiated under close medical supervision and consideration given to use of a lower starting dose. For BENICAR HCT, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosage range.

Please see full prescribing information for BENICAR and BENICAR HCT.

About Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd., Japan's second largest pharmaceutical company and a global leader in pharmaceutical innovation since 1899. The company is dedicated to the discovery, development and commercialization of innovative medicines that improve the lives of patients throughout the world.

The primary focus of Daiichi Sankyo's research and development is cardiovascular disease, including therapies for dyslipidemia, hypertension, diabetes, and acute coronary syndrome. The company is also pursuing the discovery of new medicines in the areas of glucose metabolic disorders, infectious diseases, cancer, bone and joint diseases, and immune disorders. For more information, please visit http://www.dsus.com.

For more information, please contact:

Kimberly Wix Rich Salem

Daiichi Sankyo, Inc. Daiichi Sankyo, Inc.

Office: 973 695 8338 Office: 973 695 8330

Cell: 908 656 5447 Cell: 973 563 1086


SOURCE Daiichi Sankyo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Ceremeds OSTENE(R) Improves Bone Fusion and Healing After Surgery, New Study Shows
2. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
3. St. Jude Study Shows How T Cells Machinery Dials Down Autoimmunity
4. New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
5. NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting
6. Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants
7. Community Breast Center Experience Shows Real-World Application of Breast-Specific Gamma Imaging Has Significant Impact on Clinical Care
8. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
9. FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
10. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
11. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... 14 When staff from a leading ... the difficult to adjust and uncomfortable cubital tunnel ... Products, Inc. (PPI) to develop a superior alternative. ... solutions for nearly five decades, responded with the ... which it announced today. Simple to fit ...
(Date:12/14/2009)... -- Caliper Life Sciences, Inc. (Nasdaq: ... and services for drug discovery and life sciences ... sale of Xenogen Biosciences Corporation ("XenBio"), a subsidiary ... Farms, Inc. for approximately $11 million. XenBio ... acquisition of Xenogen Corporation in 2006. Caliper ...
(Date:12/14/2009)... 14 Travelers of Interstate 70 west of ... a bit more colorful when 10 multicolored art forms ... named going home , will eventually include 34 ... graduate student at Herron School of Art and Design, ... Life. ,, Eli Lilly and Company (NYSE: ...
Breaking Medicine Technology:New Cubital Tunnel Splint Specially Designed for Comfort and Less Cumbersome Fit 2Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 2Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 3Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 4Public Art to Complete Transformation of Key Gateway into Indianapolis 2Public Art to Complete Transformation of Key Gateway into Indianapolis 3Public Art to Complete Transformation of Key Gateway into Indianapolis 4New Jersey Leaders Detail Savings for Health Reform 50576 1New Jersey Leaders Detail Savings for Health Reform 50576 2New Jersey Leaders Detail Savings for Health Reform 50576 3New Jersey Leaders Detail Savings for Health Reform 50576 4Celleration Appoints Mark T Wagner President and Chief Executive Officer 50572 1Celleration Appoints Mark T Wagner President and Chief Executive Officer 50572 2Hard To Treat Diseases 28HTDS 29 Clinical Trial Update on Therapeutic effects of Combined Treatment With Ribavirin And Tiazofurin 50568 1Hard To Treat Diseases 28HTDS 29 Clinical Trial Update on Therapeutic effects of Combined Treatment With Ribavirin And Tiazofurin 50568 2
... First 30 Patients Enrolled in Ongoing Study Presented at ... ... Abbott (NYSE: ABT ) today,announced continued positive results from ABSORB, the ... eluting stent platform for the treatment of coronary,artery disease. One-year results from ...
... Dynavax,Technologies Corporation (Nasdaq: DVAX ) today reported ... allergy therapy, to subjects as,part of an environmental exposure ... 300 subjects. Subjects are being screened based on a ... to ragweed allergen in,the chamber is being used to ...
Other Medicine Technology:Abbott Announces Positive One-Year Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 2Abbott Announces Positive One-Year Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 3Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study 2Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study 3
(Date:12/14/2009)... and HOLLYWOOD, Fla., Dec. 14 ... today a definitive agreement to acquire STARLIMS ... leading provider of laboratory information management systems, ... ,, The acquisition strengthens Abbott,s competitive position ... web-based applications to help laboratories efficiently store, ...
(Date:12/14/2009)... -- The National Organization for Rare Disorders (NORD) today ... lifetime and annual health insurance caps. In a ... distributed widely on Capitol Hill, NORD said the current ... caps to continue for most Americans, contrary to what ... reform and welcomes the promises made by President Obama ...
(Date:12/14/2009)... government controlled health care, before moving to the U.S. to practice ... his new book, Health Reform: The End of the American Revolution?, ... its threat to real health care! , ... (PRWEB) ... from Minnesota, warns Americans not to sell out their liberty for ...
(Date:12/14/2009)... of Tens of Thousands of New Chronic Hepatitis ... -- Legislation approved by Congress providing for federal ... helping to reduce tens of thousands of new ... United States, the National Viral Hepatitis Roundtable ... included in the FY 2010 Consolidated Appropriations bill ...
(Date:12/14/2009)... Exercise benefited men whose disease had been treated, hadn,t ... -- Exercise appears to reduce the risk of death ... study, which began in January 1986, included 668 men ... stage III colon cancer that had not spread (nonmetastatic ... that asked them about any new cancer and disease ...
Breaking Medicine News(10 mins):Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:NORD Calls for Immediate End to Lifetime Insurance Caps 2Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2Health News:NVHR Applauds Congressional Action to End Federal Ban on Funding Syringe Exchange 2Health News:Physical Activity May Prolong Survival After Colon Cancer 2
... India's leading vaccine manufacturer Serum Institute of India has manufactured ... vaccines // . ,The vaccine is called Td-Vac ... adolescents and adults. The new vaccine will replace the existing ... ,Td-Vac is priced at Rs 7.50 whereas the TT ...
... health the status of industry. The positive step forward ... provided under the industrial policy. Nursing homes // and ... ,The government move is expected to give a ... state, where half the population lives below the poverty ...
... a test that can detect the Hepatitis C virus using ... of Soroka University Medical Centre // in Israel carried ... functions whose blood must be passed through a machine to ... ,Such patients have a high incidence of Hepatitis C. ...
... give a false picture about coma survival and recovery rates ... felt // by coma patients and found that the ... not true as the study show that only 8% of ... with 50% upwards in real life. ,The recovery ...
... Health experts in the United States fear that if the deadly ... risk since they are vulnerable // to the H5N1 virus. ... 70 lives in Asia and has appeared in parts of Europe ... slaughtered in an effort to contain the virus. However, experts fear ...
... University of Pennsylvania have obtained valuable insights into various ... // called functional magnetic resonance imaging. It has been ... are active during an event are re-activated when a ... study shows that, as you search for memories of ...
Other Medicine News:Health News:Magnetic Resonance Imaging Can Now Be Used For Mind Reading 2
The MULTI-LINK RX PENTA Coronary Stent Systems with new ACCESS-LINK Stent Design are indicated for improving coronary luminal diameter....
Take Performance to a Higher Level....
The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
FemoStop plus system is a femoral compression system for hemostasis management. It provides a comfortable and efficient "hands off method of compressing the femoral artery and vein after diagnostic ...
Medicine Products: